花旗将加密货币交易平台Gemini Space Station的目标价从16美元下调至13美元，维持"中性"评级。(格隆 汇) ...

记者丨黎雨桐 编辑丨金珊 北京时间23日晚间，美股小幅低开，截至23时左右，道琼斯指数跌0.03%，标普500指数跌0.02%，纳斯 达克综合指数跌0.13%。 美国科技七巨头普涨，亚马逊涨超1%。费城半导体指数跌0.62%，英伟达微涨0.34%，英特尔、超威半 导体等多股下跌。 诺和诺德大涨9.5%，消息面上，诺和诺德的重磅GLP-1类药物司美格鲁肽口服版减重药正式获得美国 FDA批准。公司表示，该药物将于明年1月初在美国上市。司美格鲁肽也成为全球范围内获得批准的首 款用于减重的GLP-1类药物，此前全球都没有用于减重的GLP-1口服片剂获批。 纳斯达克中国金龙指数跌1.2%，热门中概股多数承压，小鹏汽车跌超3.7%，名创优品、蔚来、理想、B 站、金山云均跌超2%。 | < w | 纳斯达克中国金龙指数(HXC) 7590.16 -93.10 -1.21% | | | | Q | | --- | --- | --- | --- | --- | --- | | 资料 | 资讯 成分 相关基金 | | | 月度收益 | | | 小鹏汽车 XPEV.N | | 19.275 | -3.72% | | -0.37 ...

记者丨黎雨桐 编辑丨金珊 北京时间23日晚间，美股小幅低开，截至23时左右，道琼斯指数跌0.03%，标普500指数跌0.02%，纳斯达克综合指数跌0.13%。 美国科技七巨头普涨，亚马逊涨超1%。费城半导体指数跌0.62%，英伟达微涨0.34%，英特尔、超威半导体等多股下跌。 诺和诺德大涨9.5%，消息面上，诺和诺德的重磅GLP-1类药物司美格鲁肽口服版减重药正式获得美国FDA批准。公司表示，该药物将于明年1 月初在美国上市。司美格鲁肽也成为全球范围内获得批准的首款用于减重的GLP-1类药物，此前全球都没有用于减重的GLP-1口服片剂获批。 纳斯达克中国金龙指数跌1.2%，热门中概股多数承压，小鹏汽车跌超3.7%，名创优品、蔚来、理想、B站、金山云均跌超2%。 瑞达期货研究院研究员廖宏斌认为，展望未来，考虑到白银年内累计涨幅已超130%，短期内投资者对消息面的敏感度可能显著上升。任何不及 预期的数据或政策，均可能放大贵金属市场的回调风险。不过，在白银库存持续处于低位以及工业需求保持韧性的多重因素共振下，预计白银 价格将延续震荡偏强走势。 | 7590.16 -93.10 -1.21% | | --- | | ...

周二，比特币短线跌破8.7万美元，日内跌超3%，以太坊日内跌近5%。加密货币概念股走弱，Bitmine Immersion Technologies(BMNR.US)跌超6.8%，Circle(CRCL.US)跌5.9%，Robinhood(HOOD.US)跌超 4%，Strategy(MSTR.US)、Coinbase(COIN.US)跌超3%。 ...

智通财经APP讯，新火科技控股(01611)发布公告，本集团预期于截至2025年9月30日止年度将取得净亏 损不多于1000万港元，而截至2024年9月30日止年度(去年同期)则取得纯利约5630万港元。预期亏损主 要归因一项非常重大收购事项产生的预计议价收购收益约6090万港元及合并收购事项的财务业绩取得净 亏损约5860万港元。由去年同期的纯利转为本期间的净亏损亦归因于：未有就FTX存款产生一次性减值 拨备拨回约8590万港元;因收回款项而取得一次性拨回其他应收款项减值拨备约1030万港元;及加密货币 公允价值变动的浮动导致本期间收益较去年同期减少的净影响所致。 ...

Core Viewpoint - The company, New Fire Technology Holdings (01611.HK), anticipates a net loss of no more than HKD 10 million for the fiscal year ending September 30, 2025, a significant decline from a net profit of approximately HKD 56.3 million for the fiscal year ending September 30, 2024 [1] Financial Performance - The expected loss is primarily attributed to a significant acquisition that is projected to generate a bargain purchase gain of approximately HKD 60.9 million and a net loss of about HKD 58.6 million from the financial performance of the consolidated acquisition [1] - The transition from profit to loss compared to the same period last year is also due to several factors: (i) a one-time impairment reversal of approximately HKD 85.9 million related to FTX deposits not being recognized; (ii) a one-time reversal of impairment on other receivables amounting to about HKD 10.3 million due to the recovery of funds; and (iii) a net decrease in revenue compared to the same period last year caused by fluctuations in the fair value of cryptocurrencies [1]

对于这一反常规的营销策略，市场观察家指出，贝莱德此举并非单纯出于追求短期利润。ETF Store 总 裁 Nate Geraci 认为，贝莱德完全拥有费率更高、且在 2025 年表现优于比特币的黄金 ETF（IAU）等产 品，但他们却选择逆势主推 IBIT。这表明资产管理机构正致力于深化"比特币属于多元化资产组合"的 长期核心信念。FXGT 认为，这种从"业绩驱动"向"信念驱动"的转变，预示着加密货币正加速从投机资 产向标准化金融工具演变。 展望未来，FXGT 强调，贝莱德的这一立场为全球投资者提供了重要的参考坐标。当比特币被置于与现 金和主流股票同等的战略高度时，不仅增强了市场的流动性信心，也可能改变仍处于观望状态的传统投 资者的认知。在 FXGT 的视角下，2025 年将是加密资产进入深度主流化的关键一年，投资者应更加关 注这种长期战略对冲价值，而非仅仅受短期价格波动的影响。 新浪合作大平台期货开户 安全快捷有保障 12月23日，在即将跨入 2025 年之际，FXGT 认为，全球资管巨头贝莱德（BlackRock）将其比特币交易 所交易基金（IBIT）列入年度三大投资主题的举动，不仅是对单一资产的认可，更 ...

智通财经APP获悉，据知情人士透露，摩根大通(JPM.US)正考虑向机构客户提供加密货币交易服务，此 举凸显华尔街银行在数字资产领域的参与度日益提升。 据相关报道披露，摩根大通正在对其市场业务进行全面评估，旨在探索能够推出的服务类型，从而进一 步扩大自身在加密货币市场的影响力，这些服务范围或许会涵盖现货交易以及衍生品交易等多个领域。 不过，目前相关努力尚处于初步探索阶段，具体计划的制定将取决于市场是否有足够的需求来支撑任何 一款特定产品的推出。 相比之下，其竞争对手摩根士丹利(MS.US)则计划通过与数字资产基础设施提供商 Zerohash 合作，于 2026 年上半年起在其 E*Trade 平台提供加密货币交易服务。 此外，摩根大通在区块链领域亦颇为活跃。本月早些时候，该行在 Solana 区块链上为 Galaxy Digital 成 功安排了一笔短期债券发行。 据了解，近期，摩根大通在加密货币领域动作不断，其首席执行官戴蒙对加密货币的态度转变耐人寻 味。此前，戴蒙就已暗示对加密货币的态度有所软化。 在该行五月份的投资者日上，戴蒙虽重申了对加密货币"系统中的杠杆作用""滥用""恐怖主义"等方面的 担忧，但同 ...

Market Performance - Huazhong Biopharmaceutical (02396) saw a significant drop of nearly 30% on its debut and continued to decline by over 17% today. The company, established in 2012, focuses on the discovery, development, and commercialization of wound healing therapies, but has not generated any revenue from product sales yet [1] - Zai Lab (02617) fell by over 16% following the unlocking of cornerstone lock-up shares on December 23 [1] - China Rare Earth Holdings (03788) increased by over 7% after announcing plans to spin off its subsidiary "Rare Earth Gold" for independent listing on the Hong Kong Stock Exchange [1] - Goldwind Technology (02208) rose nearly 1% as the world's largest integrated green hydrogen and ammonia project, built by China Energy Engineering, officially commenced production [1] - Guizhou Zhenjiu (06979) saw an increase of over 4% after announcing a phased halt to large-scale recruitment in certain regions, which has shown significant progress during the industry's adjustment period [1] Company Developments - Taobo (06110) experienced a decline of over 7% as it reported a high single-digit year-on-year drop in total sales for its retail and wholesale business for the third quarter of the 2025/26 fiscal year [2] - CSPC Pharmaceutical Group (01093) rose nearly 6% after its chairman increased his stake by acquiring 13.454 million shares at approximately HKD 8.1957 per share, totaling around HKD 110 million [2] - Shandong Gold (01787) increased by nearly 6% as spot gold prices reached a historical high of USD 4,400 per ounce, with predictions from JPMorgan estimating an average gold price of USD 5,055 per ounce by Q4 2026 [2] Industry Trends - The dairy sector saw active trading, with companies like Modern Dairy (01117), Original Ecology Dairy (01431), Mengniu Dairy (02319), and China Feihe (06186) all experiencing gains. This follows the Ministry of Commerce's announcement of temporary anti-subsidy measures on dairy products imported from the EU starting December 23, 2025 [3] - CIMC Enric (03899) rose by over 7% after signing a memorandum of cooperation with the Yangpu Economic Development Zone Management Committee at a recent offshore wind power industry chain conference [4] US Market Highlights - The US solar energy sector saw strong performance, with companies like Sunrun (RUN.US) and Canadian Solar (CSIQ.US) rising by 10.84% and 10.78% respectively, following a Goldman Sachs report indicating a structural investment window in the solar sector [5] - Cytokinetics (CYTK.US) increased by 4.59% after receiving priority review approval for its innovative drug, which treats obstructive hypertrophic cardiomyopathy in adults [5] - Tesla (TSLA.US) rose by 1.56% as a prominent analyst expressed optimism about the company's expansion of its autonomous taxi service by 2026 [6] - Quantum computing stocks surged, with D-Wave Quantum (QBTS.US) rising by 20.02% and IonQ Inc (IONQ.US) by 11.1% [6] - Cryptocurrency stocks continued to rise, with Hut 8 (HUT.US) increasing by 14.21% as Bitcoin and Ethereum prices surged [7]

智通财经APP获悉，周一，美股加密货币概念股延续上涨，Hut 8(HUT.US)涨近12%，IREN(IREN.US)涨 超7%，Circle(CRCL.US)涨超3%，Coinbase(COIN.US)、BitMine Immersion(BMNR.US)涨近3%， Robinhood(HOOD.US)涨超2%。消息面上，比特币大涨2%，重新站上90000美元;以太坊大涨2.5%，重 新站上3000美元。 ...